The operational scope was adults and older adolescents aged 17–19 years, with post-acute recovery defined as seven days to five years after injury. Sources describing paediatric, adult, mixed-age or unstated age populations were retained as explicit metadata categories. Acute neurosurgery, resuscitation fluids, osmotherapy, acute neuroprotection and intensive-care interventions were excluded from the post-acute rehabilitation synthesis.

Researchers searched English-language PubMed records from database inception through 21 August 2026 using seven complementary retrieval strands covering rehabilitation and function, cognitive rehabilitation, physical symptoms, sleep and vestibular care, mental health and behavioural recovery, participation and social recovery, care delivery, implementation and access, and outcome measurement or prognosis. The broad probes returned 202,254 overlapping hits, while the high-level retrieval paths returned 10,129 overlapping hits. These were overlapping retrieval counts rather than denominators for independent studies.

Deduplication produced 2,546 unique PubMed identifiers. EFetch supplied parseable XML metadata for 2,529 records, while 17 requested identifiers remained in a missing-record audit. A prespecified rule-based score combined evidence type, recency, domain relevance, recovery and population signals and a direct-TBI title signal, with penalties for animal, paediatric-only, acute or surgical and biomarker-only records. The score organized the parsed corpus into a priority subset of 220 records, and a separate deterministic calculation reproduced the stored score for all 2,529 records without mismatch.

The illustrative registry comprised 50 PubMed-indexed sources published from 2020 through 2026: 10 guidelines or consensus documents, 16 intervention syntheses, 10 implementation or service-evidence sources, 13 measurement or prognostic-evidence sources and one protocol or methods source. The protocol was retained as a methods reference and was not interpreted as completed effect evidence. No numerical quota was imposed by recovery domain. Each source received one title/abstract-audited primary recovery domain, one nominal source-role category and a source-specific selection rationale.

Source-level validation was conducted without prospective clinical validation. Two reviewers independently assessed 200 records sampled equally across four priority-score strata without access to the automated classifications. Their pre-consensus agreement was 190 of 200, or 95.0%, and all 10 disagreements were resolved by consensus. Specialists in neurosurgery, neurology, neurorehabilitation and psychiatry then reviewed all 50 curated sources and confirmed the prespecified source-role, primary-domain and clinical-context classifications.

The registry contained 12 sources in mental health and behaviour, 10 in multidisciplinary rehabilitation, nine in symptoms, sleep and physical recovery, seven in cognitive rehabilitation, seven in implementation and access, four in participation and social recovery and one in outcome measurement and prognosis. These counts describe the composition of the curated registry, not the importance or strength of evidence for any domain.

Reporting of clinical context was uneven across the 50 sources. Age language was absent from 23, while 20 contained adult language, five contained mixed adult and paediatric or adolescent language and two contained paediatric or adolescent language. General or pre-existing comorbidity language appeared in one source. Injury severity was stated in 20 sources: 13 referenced mild TBI or concussion and seven moderate-to-severe TBI; severity was unstated in 30. Recovery-time language appeared in 15 sources. Care setting was not stated in 38; seven mentioned rehabilitation or transition settings, two digital or remote settings, two vocational or education settings and one outpatient or community setting.

No molecular or biochemical marker, cell-type or brain-region signal appeared in the curated title and abstract metadata. The authors described these zero counts as reporting results, not evidence that the corresponding biology is clinically unimportant. The analyses were descriptive and did not calculate treatment effects, certainty ratings, risk-of-bias assessments, causal estimates, patient-level predictions, net benefit or treatment-effect direction.

Important limitations constrain interpretation. The search used PubMed and English-language records, and the 50-source registry was curated rather than derived from a completed multi-database, dual-reviewer full-text systematic review. Title and abstract metadata cannot establish risk of bias, overlap between primary studies, treatment-effect direction, effects of prior treatment, outcome harmonization, certainty of evidence, net benefit or patient-level prognosis. TBI-RECOVER is therefore a transparent structure for locating and describing high-level post-acute TBI recovery evidence, not a clinical decision algorithm, treatment recommendation or validated prognostic system.

Subject of Research: Architecture of a curated evidence registry for post-acute traumatic brain injury recovery

Article Title: Post-acute traumatic brain injury recovery: architecture of an illustrative curated evidence registry

Article References: Cao, F., Xu, L., Wang, W., Yu, T., & Xu, G. (2026). Post-acute traumatic brain injury recovery: architecture of an illustrative curated evidence registry. Frontiers in Neurology, 17, Article 1979438. https://doi.org/10.3389/fneur.2026.1979438

Image Credits: AI Generated

DOI: 10.3389/fneur.2026.1979438

Keywords: traumatic brain injury, post-acute recovery, evidence registry, rehabilitation, clinical decision context, PubMed, care settings, outcome measurement, implementation, Post-acute, traumatic, brain

The technical machinery behind the study is worth understanding, because bibliometrics is a discipline with its own rigor. The authors conducted a scientometric analysis using standardized search strategies across two of the largest biomedical literature databases, then applied PRISMA-style screening principles to isolate publications genuinely relevant to traditional and complementary medicine in cancer supportive care. For the mapping and visualization work, they used VOSviewer, a widely adopted software tool that constructs networks from bibliographic data and clusters them algorithmically. Co-authorship networks revealed patterns of collaboration between researchers and institutions; country-level analysis exposed the geography of output and citation; keyword co-occurrence mapping grouped the vocabulary of thousands of abstracts into thematic clusters; and citation structure analysis identified which works the field treats as foundational. Each of these lenses captures a different dimension of scientific activity, and together they turn an undifferentiated pile of nearly six thousand papers into an interpretable map.

The temporal trends tell a clear story of acceleration. Research output showed only modest growth during the early 2000s, a period when complementary medicine was still largely treated with skepticism in mainstream oncology journals. After 2010, the field entered a phase of sustained expansion, and the peak of activity arrived between 2020 and 2024. That late surge coincides with several converging forces: the maturation of integrative oncology as a recognized subspecialty, the publication of clinical practice guidelines endorsing evidence-based integrative therapies during and after breast cancer treatment by the Society for Integrative Oncology and their endorsement by the American Society of Clinical Oncology, and the World Health Organization’s escalating institutional commitment to traditional medicine, including its global traditional medicine centre and the Global Traditional Medicine Strategy 2025–2034. The pandemic years also intensified interest in supportive care broadly, as clinicians confronted the symptom burden of patients who could not easily access conventional services.

Geographically, the analysis confirmed what many observers suspected but had never quantified at this scale. The United States emerged as the dominant contributor across every metric examined: publication volume, citation impact, and international collaboration. China and the United Kingdom followed as the next most influential producers. This concentration matters because the modalities under study, from Traditional Chinese Medicine and Ayurveda to Unani, Kampo, Jamu, traditional Korean medicine, naturopathy, and anthroposophic medicine, are rooted in regions and health systems that do not map neatly onto the Anglo-American research establishment. The authors found that collaboration networks were globally distributed but regionally concentrated, with limited cross-regional integration. In practical terms, Asian research communities studying traditional medicine systems often publish and collaborate within their own regional clusters, while North American and European groups form largely separate networks, and the bridges between them remain thin.

The thematic analysis may be the most revealing part of the study. Keyword clustering showed a strong patient-centered orientation across the literature, with quality of life, symptom management, and supportive care outcomes forming the gravitational center of the field. This is a significant departure from earlier eras of complementary medicine research, which often fixated on whether herbal preparations could shrink tumors or extend survival, questions where the evidence remained weak and controversy ran high. The modern literature instead asks how these modalities help patients live better through treatment: managing cancer-related fatigue, chemotherapy-induced nausea, pain, anxiety, sleep disturbance, and the diffuse distress of survivorship. The keyword clusters also highlighted the growing embedding of traditional and complementary medicine modalities within the framework of integrative oncology, where they are studied as adjuncts to, rather than alternatives for, conventional treatment.

Why does this shift toward patient-centered outcomes matter scientifically? Part of the answer lies in the epidemiology of cancer itself. Global cancer statistics from the GLOBOCAN 2022 estimates document tens of millions of new cases annually across 185 countries, and as survival improves, the population of people living with and beyond cancer grows correspondingly. Surveys reviewed in the study’s supporting literature indicate that a substantial proportion of cancer patients use complementary and alternative medicine, with meta-analytic evidence showing especially high prevalence in Asian countries and documented decade-over-decade increases in places like Jordan. When large numbers of patients are already using these therapies, often without telling their oncologists, the scientific and clinical imperative becomes harm reduction and evidence-informed integration rather than prohibition. Quality of life data themselves carry prognostic weight, with prior literature linking quality of life measures to survival outcomes, which gives symptom-focused research a legitimacy that extends beyond comfort alone.

The study’s authors were candid about the field’s weaknesses, and their conclusions read as both a progress report and a warning. Fragmented collaboration networks mean that findings generated in one region may not be replicated, critiqued, or even noticed in another, slowing the accumulation of reliable evidence. Uneven geographic representation raises the possibility that traditional medicine systems with deep regional roots, such as the AYUSH systems of India or the herbal traditions of Indonesia and Japan, are underrepresented in the high-impact literature relative to their actual clinical use. Methodological variability is perhaps the most consequential problem: when studies of acupuncture, herbal medicine, yoga, or mind-body interventions use inconsistent outcome measures, comparator arms, and quality standards, systematic reviewers and guideline developers struggle to synthesize the evidence into clinical recommendations. The authors explicitly call for stronger international collaboration and well-designed clinical studies to support the evidence-informed integration of traditional and complementary medicine within supportive oncology.

There is also a structural dimension to the findings that extends beyond medicine into science policy. The acknowledgment section of the paper credits the library of the Central Council for Research in Ayurvedic Sciences under India’s Ministry of AYUSH, a detail that illustrates how national governments are now investing institutional resources in traditional medicine research infrastructure. The WHO’s strategy documents signal that this is a coordinated global project, not a fringe movement. For bibliometricians, the study demonstrates the continuing utility of network visualization tools like VOSviewer for auditing an entire field’s health, identifying orphan topics that lack attention, and exposing collaboration gaps that funding agencies could target. For clinicians, it offers reassurance that the literature they might consult on supportive care is growing rapidly, alongside a caution that its geographic and methodological foundations remain uneven.

The broader takeaway is that traditional and complementary medicine in cancer care has crossed a threshold. What was once a scattered collection of small studies, often published in specialized journals and read by a self-selected audience, has become a substantial, measurable, and internationally active research domain with a defined patient-centered agenda. The 5,770 publications analyzed here represent twenty-five years of accumulating effort to ease the symptom burden of cancer treatment using every tool available, from ginger’s well-documented anti-nausea pharmacology to structured mind-body programs. Whether the next decade of that effort produces the rigorous, cross-regional, methodologically consistent evidence base that the field’s own mapping says it needs will depend on whether researchers in Boston, Beijing, London, and Patiala can finally start reading, citing, and building on each other’s work.

Subject of Research: Bibliometric mapping of global research trends in traditional and complementary medicine for cancer supportive care

Article Title: Global research trends in traditional and complementary medicine for cancer supportive care: a bibliometric analysis (2000–2025)

Article References: Gajarmal, A., S., M., & Baheti, S. (2026). Global research trends in traditional and complementary medicine for cancer supportive care: a bibliometric analysis (2000–2025). Supportive Care in Cancer, 34(10), Article 958. https://doi.org/10.1007/s00520-026-11207-7

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11207-7

Keywords: traditional and complementary medicine, cancer supportive care, integrative oncology, bibliometric analysis, quality of life, symptom management, VOSviewer, PubMed, Scopus, international collaboration, Traditional Chinese Medicine, Ayurveda

The problem the researchers set out to solve is deceptively simple to state and notoriously hard to crack. Automatic text summarization has been a goal of natural language processing since the earliest days of the field, but the task splits into two broad philosophies. Extractive summarization selects existing sentences from a document and stitches them together, guaranteeing grammatical output but often producing a choppy, disjointed result that misses the flow of the original argument. Abstractive summarization, by contrast, generates entirely new sentences that paraphrase the source, much as a human writer would. Abstractive methods produce more readable, coherent summaries, but they demand enormous computational resources and struggle when fed very long documents, because the neural networks behind them have limited attention spans and can lose track of the most important content buried deep in the text.

TextSummNet’s central insight is that these two approaches are stronger together than either is alone. The system operates in two distinct stages. In the first stage, an extractive module scans the full document and selects the sentences most relevant to the document’s core meaning. This acts as a filter, dramatically shrinking the amount of text that the downstream model must process. Rather than asking a transformer network to digest a ten-thousand-word scientific paper in one gulp, the pipeline hands it a distilled, information-dense subset of the original. The researchers then apply an attention-guided filtering step that further refines this material, weighting the selected content according to how much each portion contributes to the overall meaning before it reaches the generation stage.

The second stage is where the abstractive magic happens. An advanced transformer-based model takes the filtered, condensed input and generates the final summary in fresh, natural language. Transformers, the architecture that underpins virtually all modern language models, rely on attention mechanisms that let the network weigh the relevance of every word against every other word in the input. By feeding the transformer a pre-filtered document rather than the raw text, TextSummNet sidesteps one of the most persistent weaknesses of abstractive summarization: the tendency of models to drift, repeat themselves, or hallucinate content when confronted with redundant, sprawling inputs. The extractive filter effectively clears away the noise so the generative model can focus on signal.

Long documents pose a particularly nasty set of challenges that the team explicitly targeted. Scientific papers, legal judgments, and medical reports are riddled with redundant information, restating the same findings in the abstract, introduction, results, and discussion. They feature complicated hierarchical structures, with sections, subsections, figures, and citations interleaved in ways that confuse linear text models. And they deploy dense domain-specific language that general-purpose models may misinterpret. By combining a relevance-driven extractive filter with attention-guided refinement, TextSummNet addresses all three problems at once: redundancy is pruned, structure is simplified by reducing the document to its most load-bearing sentences, and domain language is preserved in the sentences that survive the filter, giving the abstractive model accurate raw material to paraphrase.

To find out whether this hybrid design actually works, the researchers benchmarked TextSummNet against established baseline models on three of the most demanding datasets in the summarization literature: CNN/DailyMail, a collection of long news articles paired with multi-sentence summaries; PubMed, a repository of biomedical abstracts drawn from scientific papers; and ArXiv, a trove of dense technical preprints spanning physics, mathematics, and computer science. These three benchmarks deliberately span a range of document styles, from journalistic prose to highly technical scientific writing, testing whether a summarization system can generalize across domains rather than excelling on just one type of text.

The evaluation relied on ROUGE scores, the standard metric family for summarization quality. ROUGE-1 measures the overlap of individual words between a generated summary and a reference summary written by a human, ROUGE-2 measures the overlap of two-word sequences, and ROUGE-L captures the longest common sequences of words, rewarding summaries that follow similar structural trajectories to their human-written counterparts. Across all three benchmarks, TextSummNet posted significantly higher ROUGE-1, ROUGE-2, and ROUGE-L scores than every baseline model it was compared against. In practical terms, that means the system’s summaries contained more of the right content, captured more of the important word pairings and phrases, and mirrored the structure of human summaries more closely than the outputs of competing approaches.

The significance of those numbers extends well beyond a leaderboard. High ROUGE-2 and ROUGE-L scores in particular suggest that the two-stage design is not merely cherry-picking easy sentences but genuinely producing fluent, well-organized summaries of complex material. For the scientific community, the implications are tantalizing: a system that can reliably condense ArXiv preprints or PubMed articles could help researchers triage the flood of new publications in their fields, surfacing the papers that deserve a careful read. For medicine and law, where documents routinely run to dozens of pages and the cost of missing a key detail is high, a filtering-plus-generation pipeline that keeps the essential content while cutting the noise could become a practical assistive tool rather than a laboratory curiosity.

The study also lands at a moment when the field of text summarization is undergoing rapid transformation. Recent surveys have traced the evolution from statistical methods through neural sequence models to today’s large language models, and researchers are actively exploring graph-based extractive techniques, reinforcement learning for abstractive generation, chain-of-thought reasoning for structured long documents, and even iterative summarization through conversational AI. Somu and her colleagues’ contribution to this crowded landscape is architectural discipline: rather than scaling up a single monolithic model, they show that a carefully staged pipeline, in which an extractive filter prepares the ground for an abstractive transformer, can outperform more brute-force approaches. It is a reminder that in machine learning, how you feed a model can matter as much as how big the model is.

The work, conducted at the Department of Computer Science and Engineering at Anna University’s College of Engineering in Guindy, was not funded by any external organization, and the authors report no competing interests. They note that AI-assisted tools, including ChatGPT, were used to refine the language of the manuscript, while all technical content and analysis were developed and validated by the team itself. As the volume of human-written text continues its relentless climb, systems like TextSummNet point toward a future in which the distance between a sprawling document and its essential meaning shrinks to a single click, and the knowledge locked inside the world’s libraries becomes available to anyone with seconds, rather than hours, to spare.

Subject of Research: Hybrid extractive-abstractive neural text summarization of long documents

Article Title: TextSummNet: extractive filtering model and advanced transformer based model for abstractive summarization

Article References: Somu, R., NandaKumar, R., PharthaSarathy, A., & Sugan, S. (2026). TextSummNet: extractive filtering model and advanced transformer based model for abstractive summarization. Neural Computing and Applications, 38(19), Article 765. https://doi.org/10.1007/s00521-026-12535-9

Image Credits: AI Generated

DOI: 10.1007/s00521-026-12535-9

Keywords: text summarization, TextSummNet, transformers, natural language processing, extractive summarization, abstractive summarization, ROUGE score, CNN/DailyMail, PubMed, ArXiv, machine learning, attention mechanism

The study is a bibliometric analysis, a method that treats the scientific literature itself as the object of investigation. Rather than synthesizing findings from individual experiments, bibliometrics measures the shape of a field: how many papers are published each year, who writes them, where they appear, which journals carry the most cited work, and which concepts cluster together across thousands of studies. Lițan searched three of the largest scholarly databases, the Web of Science Core Collection, Scopus, and PubMed, for publications dated between January 1, 2014 and June 20, 2024. The initial search returned 2,287 publications, which were then screened down to 1,606 studies that met the criteria for inclusion.

The technical machinery behind the analysis came from the Biblioshiny application, a graphical interface built on the Bibliometrix package in the R statistical environment. Two complementary strands of analysis were performed. The first, performance analysis, quantified scientific production over time, mapped author affiliations, identified the most cited journals, and traced collaboration networks between institutions and countries. The second, thematic analysis, examined keyword frequency, tracked how research trends shifted year by year, built co-occurrence networks showing which concepts are studied together, and constructed thematic maps that plot research themes according to their prominence and degree of internal development.

The headline finding is a substantial and sustained increase in research output across the study period. Publications linking digital transformation to mental health did not grow in a linear trickle; the field expanded markedly as smartphones, social media platforms, remote work arrangements, and digital health tools became everyday realities. This growth reflects a broader recognition that psychological wellbeing is no longer separable from digital life. As societies digitized, researchers increasingly asked whether the same technologies that promise convenience and connection might also carry costs for mood, anxiety, attention, and social relationships.

The analysis also reveals a strongly uneven geography of scholarship. Key contributors and collaboration patterns cluster in particular regions and institutions, meaning that the questions asked about digital life and mental health have been shaped disproportionately by a limited set of research communities. This matters because the psychological consequences of digitalization are not uniform across the globe. Patterns of technology adoption, labor market structures, cultural attitudes toward online life, and access to digital mental health services all vary widely, and a literature concentrated in a handful of countries risks producing conclusions that travel poorly to other contexts.

Perhaps the most striking contribution of the study is its map of what the literature has ignored. Lițan identifies significant gaps concerning the relationship between mental health and emerging components of digitalization, specifically remote work, the Internet of Things, virtual reality, and blockchain. These are not marginal technologies. Remote work became the default mode of employment for millions of people almost overnight during the pandemic era, yet its psychological effects remain comparatively underexplored in this body of literature. The Internet of Things now embeds sensors and connected devices into homes, workplaces, and even wearables that track physiological and behavioral data continuously. Virtual reality has moved from gaming into clinical settings for exposure therapy and rehabilitation. Blockchain underpins new economic and social infrastructures. Each of these technologies reshapes daily routines, social interaction, and stress exposure in ways that psychology has only begun to measure.

The thematic analysis shows a field in motion. Keyword trends and longitudinal thematic evolution indicate that research directions have emerged rapidly in response to technological advances, with artificial intelligence and digital environments standing out as the fastest-growing frontiers. This is where the study’s timing becomes especially significant. The analysis deliberately captures the field up to mid-2024, providing a baseline snapshot before the accelerated expansion of AI-driven research that followed. Large language models and generative AI systems have since flooded both public discourse and the scientific literature, and the study documents precisely what the research landscape looked like at the moment that wave began to build.

That baseline has practical value for researchers and funders alike. Knowing which themes dominated the decade from 2014 to 2024, and which were neglected, allows the field to prioritize deliberately rather than chase each new technology as it arrives. The findings carry implications for mental health research prioritization, for clinical awareness among practitioners whose patients increasingly live digitally saturated lives, and for the development of evidence-based interventions designed to address the psychological impact of emerging digital technologies. Without a clear map of what is known and unknown, clinical guidance risks lagging far behind the technologies patients actually use.

The methodological approach also deserves attention from anyone following how science studies itself. By combining performance metrics with thematic mapping, the study avoids the narrowness of simple publication counts. Co-occurrence networks expose the conceptual architecture of the field, showing which ideas are tightly integrated and which sit at the periphery. Thematic maps distinguish mature, well-developed research themes from emerging or declining ones, offering a dynamic picture rather than a static census. This dual lens is what makes the identified gaps credible: they emerge from the structure of the literature itself rather than from any single reviewer’s judgment.

As digital transformation accelerates, the questions raised by this analysis will only grow more urgent. The decade from 2014 to 2024 established digital transformation and mental health as a legitimate and rapidly growing research area, but it also left large territories uncharted, from the psychological toll of always-on connectivity in remote work to the mental health dimensions of ambient sensing and immersive virtual environments. With artificial intelligence now reshaping the research agenda at unprecedented speed, the study serves as both a record of where the field has been and a warning about where it has yet to go. The full open access article, published in Discover Psychology, is available for researchers, clinicians, and policymakers who need a rigorous starting point for navigating the psychological consequences of an increasingly digital world.

Subject of Research: Bibliometric analysis of research trends on digital transformation and mental health from 2014 to 2024

Article Title: Bibliometric analysis of research trends in digital transformation and mental health from 2014 to 2024

Article References: Lițan, D.-E. (2026). Bibliometric analysis of research trends in digital transformation and mental health from 2014 to 2024. Discover Psychology. https://doi.org/10.1007/s44202-026-00891-5

Image Credits: AI Generated

DOI: 10.1007/s44202-026-00891-5

Keywords: bibliometrics, digital transformation, mental health, artificial intelligence, remote work, Internet of Things, virtual reality, blockchain, Web of Science, Scopus, PubMed, research trends

The technology in question is histotripsy, a non-invasive ablation method that uses precisely focused bursts of ultrasound energy to mechanically destroy tissue. Rather than burning tumors with heat, freezing them with cryogenic probes, or killing cells with electric fields, histotripsy generates controlled cavitation bubbles at the focal point of an ultrasound beam. These bubbles expand and collapse in microseconds, creating mechanical forces that fragment cells into subcellular debris. The body then processes this debris naturally, and because the technique is non-thermal, it spares surrounding structures such as blood vessels and bile ducts from the collateral damage that thermal methods can inflict. On paper, it sounds like everything a patient could want: no incisions, no radiation, and no heat.

Researchers led by Francois H. Cornelis, Rozan Bokhari, and Stephen B. Solomon of Memorial Sloan Kettering Cancer Center set out to quantify how public enthusiasm for histotripsy compares with its scientific foundation. They combined two complementary data streams spanning 2004 through 2025. To measure public interest, they extracted annual Search Volume Index values from Google Trends for six percutaneous ablation modalities: radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, pulsed electric field therapy, and histotripsy. To measure academic output, they counted yearly PubMed publications for each technique. They then applied formal statistical tools, using Mann-Kendall tests to determine whether trends were significant, Spearman rank correlation coefficients to measure how tightly public interest tracked academic output, and third-degree polynomial regression models to forecast trajectories through 2030.

The numbers are remarkable. Between 2020 and 2025, online searches for histotripsy increased by 31,100 percent, a rise so steep that the authors report a p-value below 0.001, meaning the probability of such a surge occurring by chance is vanishingly small. No other ablation technology comes close. Academic output grew as well, with PubMed publications on histotripsy rising 185.7 percent over the same period, a statistically significant increase. The forecasting models project that search interest will climb a further 350 percent and publications will rise 75 percent by 2030, with histotripsy and microwave ablation showing the strongest upward trajectories of all the modalities analyzed.

But the most revealing finding is not the magnitude of the surge. It is the order in which things happened. When the researchers computed Spearman correlation coefficients between public search interest and academic publications, histotripsy scored 0.79, the lowest of the modalities examined. Microwave ablation scored 0.83 and radiofrequency ablation 0.87, values indicating that for those established techniques, public attention rose roughly in step with the accumulating scientific literature. Histotripsy’s lower correlation captures an inversion of the classic sequence: public awareness exploded well before robust clinical evidence existed to support it. Geographic analysis reinforced how unusual this is. A Gini coefficient of 0.216, a measure of statistical dispersion where lower values indicate more even distribution, showed that interest in histotripsy is spread broadly across the country rather than concentrated in the academic medical centers where the research is actually being conducted.

The authors attribute this reversed pathway to vigorous commercial promotion combined with the technique’s inherent conceptual appeal. Early marketing has emphasized theoretical immunologic effects, the idea that destroying tumors mechanically might release antigens that stimulate a systemic anti-cancer immune response, along with broad claims of therapeutic potential. Yet regulatory clearance for histotripsy remains limited to narrow, ultrasound-guided liver indications. The gap between what is being promoted and what has been proven is where the authors see danger. Patients arrive at clinics with expectations shaped by promotional materials rather than peer-reviewed data, pressuring physicians to offer treatments that lack comprehensive validation. Hospitals, fearing competitive disadvantage, acquire expensive systems even when clinical need may not justify the investment. Resources flow toward technologies with limited demonstrated benefit while established treatments receive diminished attention.

This pattern has precedents, and they are cautionary ones. Irreversible electroporation, a technique that kills cells by permeabilizing their membranes with high-voltage electric pulses, experienced a similar wave of enthusiasm, rising quickly before plateauing as clinical trials revealed practical limitations. High-intensity focused ultrasound faced comparable challenges when its promise outpaced its reality. In both cases, the technology found legitimate but narrower roles than early advocates had claimed. The lesson, the authors argue, is that scientific rigor must be maintained even, and perhaps especially, when a technology’s potential seems extraordinary.

The current evidence base for histotripsy remains thin by the standards that typically govern adoption in oncology. Published studies are predominantly single-center experiences with limited follow-up periods. The purported immunologic effects, which feature prominently in promotional narratives, remain entirely theoretical in clinical application, even though related work on pulsed electric fields has shown time-dependent cytokine responses in preclinical liver ablation models and preclinical histotripsy studies have demonstrated encouraging safety profiles. None of this amounts to clinical proof that histotripsy triggers meaningful systemic anti-tumor immunity in patients. Meanwhile, patients seeking non-invasive options encounter marketing that the authors say overstates capabilities while minimizing limitations, raising ethical questions about informed consent and the fair allocation of healthcare resources. The pressure for rapid return on investment incentivizes application beyond established indications, which could compromise both patient safety and scientific integrity.

None of this diminishes histotripsy’s genuine promise, and the authors are careful to say so. Preclinical work demonstrates precise mechanical tissue destruction with encouraging safety, and the non-thermal mechanism offers theoretical advantages that merit serious investigation. The technology may ultimately transform minimally invasive oncology. But responsible development, they argue, requires prioritizing clinical validation over market expansion. Rigorous multicenter trials with standardized protocols must establish efficacy before promotional campaigns drive adoption. The interventional oncology community, in their framing, faces a defining moment: it can allow marketing momentum and investor enthusiasm to push premature integration, risking patient harm and professional credibility when outcomes fail to match promises, or it can channel the surge of public interest toward accelerated but methodologically sound validation, maintaining transparent communication about what the technology can and cannot yet do.

The broader significance of this study extends beyond a single technology. By quantifying the divergence between public interest and academic output, the researchers have provided a measurable indicator of a phenomenon that clinicians have long observed anecdotally: the internet age allows demand for a treatment to materialize before the evidence to justify it. Only through large, rigorous studies demonstrating durable clinical benefit, the authors conclude, can widespread histotripsy adoption serve patients rather than shareholders. Whether the field heeds that warning, or repeats the cycle of hype and disappointment that has caught previous technologies, will be one of the more consequential stories in cancer medicine over the coming decade.

Subject of Research: Public and academic interest trends in percutaneous tumor ablation technologies, focusing on histotripsy's atypical adoption pathway

Article Title: Public interest and academic trends in percutaneous ablations: histotripsy’s reversed innovation pathway

Article References: Cornelis, F. H., Bokhari, R., & Solomon, S. B. (2025). Public interest and academic trends in percutaneous ablations: histotripsy’s reversed innovation pathway. CVIR Oncology, 1(1), Article 14. https://doi.org/10.1007/s44343-025-00017-z

Image Credits: AI Generated

DOI: 10.1007/s44343-025-00017-z

Keywords: histotripsy, percutaneous ablation, interventional oncology, Google Trends, PubMed, medical innovation, commercial promotion, clinical validation, ultrasound therapy, tumor ablation, irreversible electroporation, informed consent

The scale of the problem is easy to underestimate. Curated databases do exist that catalogue which proteins carry which modifications and at which amino acid positions, and these resources are indispensable for experimentalists planning experiments or interpreting mass-spectrometry data. But most of those databases cover only a limited number of PTM types, and they are not updated regularly. Meanwhile, the volume of PTM-related findings buried in PubMed abstracts keeps growing year after year. The result is a widening information gap: knowledge that has already been discovered and published sits locked inside unstructured text, inaccessible to computational analysis, while the manual curation effort needed to unlock it falls further behind. Building a separate, dedicated text-mining system for every one of the hundreds of known PTM types is simply not feasible.

GenPTM attacks this problem with a deliberately generalizable design. The central insight behind the framework is that, despite the bewildering chemical diversity of PTMs, the sentences scientists use to describe them are remarkably similar in structure. A paper might report that a protein is ubiquitinated at a lysine residue, phosphorylated on a serine, or methylated at an arginine, but the underlying linguistic pattern, in which a protein, a modification event, and a site are linked together, repeats across modification types. Rather than teaching a model the vocabulary of each modification separately, the Delaware team replaces PTM-specific modification names and chemical group mentions with generic placeholders. This unified text representation strategy forces the model to focus on the shared textual patterns that express modification events, regardless of which particular modification is being discussed.

On top of this representation, the researchers fine-tuned a classifier built on BiomedBERT, a language model pre-trained on biomedical text. The classifier’s job is deceptively simple: given a candidate protein or a candidate amino acid site in a sentence, decide whether that protein or site is genuinely modified in the context described. This is a harder judgment than it sounds, because scientific prose is full of negations, speculations, and references to other studies. A sentence saying that a site was not found to be phosphorylated, or that phosphorylation at a position is suspected but unconfirmed, must be distinguished from a clean report of an observed modification. The fine-tuned BiomedBERT classifier makes that determination for each candidate, and a post-processing module then assembles the individual decisions into final predictions: modified proteins, modified sites, or complete protein-site pairs.

The training and evaluation strategy is what makes the claim of generalizability convincing. The model was trained on data covering five major PTM types, including well-studied modifications such as ubiquitination and phosphorylation, which dominate the literature and the curated databases. The real test, however, came from evaluation on eight additional PTM types that the model had never seen during training. These included PTMs that are mentioned only rarely in scientific articles, such as citrullination and AMPylation, precisely the kinds of modifications for which dedicated curation resources are weakest and the need for automated extraction is greatest. A system that only works on abundant, well-documented modifications would offer little advantage over existing tools; GenPTM was designed to work on the long tail.

The results reported in the paper are striking. Across all PTM types tested, including the eight held-out modifications, GenPTM achieved F1-scores ranging from 92 percent to 96 percent across three different evaluation categories. The F1-score is a standard metric that balances precision, the fraction of predicted modifications that are correct, against recall, the fraction of true modifications that are found. Scores in the mid-nineties for modification types the model was never explicitly trained on indicate that the placeholder-based representation genuinely transfers knowledge about how modification events are expressed in text. In practical terms, a curator or database builder could point GenPTM at a PTM type with little or no dedicated training data and still expect reliable extraction of modified proteins and their sites from PubMed abstracts.

The implications for proteomics research extend beyond convenience. PTM-agnostic information extraction means that newly discovered or obscure modification types can be surveyed systematically as soon as reports appear, without waiting for a specialized tool or a funded curation project. It also means that existing PTM databases could be updated far more frequently, with automated systems flagging candidate modifications from the newest literature for expert review. Because the framework operates on abstracts, the most accessible layer of the literature, it can scale to the full breadth of PubMed rather than being restricted to a handful of model organisms or heavily studied protein families. The authors position the work as a viable solution for automated PTM knowledge discovery, and the architecture suggests a path toward text-mining systems that generalize across related biomedical relation-extraction problems as well.

The project reflects a substantial collaborative effort. The work was carried out by Shovan Bhowmik, Chuming Chen, Cathy Wu, and K. Vijay-Shanker at the University of Delaware, together with Karen Ross of Georgetown University Medical Center. The team acknowledges the valuable expertise in data curation contributed by Dr. Cecilia Arighi of the University of Delaware, as well as the dedicated curation efforts of Amos Nyabuti and Winnie Aketch, master’s students at Delaware’s Center for Bioinformatics and Computational Biology, who helped develop the training and testing corpora on which the framework depends. High-quality annotated corpora are the quiet foundation of every successful biomedical language model, and the paper is a reminder that advances in artificial intelligence for biology rest on meticulous human annotation work.

Financial support came from multiple National Institutes of Health grants, including R35GM141873, U54GM104941, and P20GM103446, along with 1R24GM146616-01 and, from the NIH Office of Strategic Coordination and the Common Fund, 1OT2OD032092. The article is published open access under a Creative Commons Attribution 4.0 license, meaning that any research group, database curator, or tool developer can read, reuse, and build upon the work without restriction. The paper was received on 30 April 2026, accepted on 14 September 2026, and published on 24 September 2026, carrying the DOI 10.1186/s12859-026-06663-1.

For a field drowning in its own literature, GenPTM offers something rarer than another incremental benchmark improvement: a demonstration that a single, thoughtfully designed system can serve the entire spectrum of post-translational modifications, from the phosphorylation events catalogued in thousands of papers to the citrullination and AMPylation events scattered across a comparative handful. If the framework’s generalization holds as it is applied more broadly, the tedious bottleneck between publication and curated knowledge could begin to close, letting the proteins’ chemical vocabulary be read as fast as scientists can write it.

Subject of Research: Automated information extraction of protein post-translational modifications from scientific literature using a generalizable natural language processing framework

Article Title: GenPTM: a generalizable framework for protein post-translational modification information extraction from the scientific literature

Article References: Bhowmik, S., Ross, K., Chen, C., Wu, C., & Vijay-Shanker, K. (2026). GenPTM: a generalizable framework for protein post-translational modification information extraction from the scientific literature. BMC Bioinformatics. https://doi.org/10.1186/s12859-026-06663-1

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06663-1

Keywords: post-translational modification, information extraction, text mining, BiomedBERT, phosphorylation, ubiquitination, proteomics, PubMed, natural language processing, protein sites, BMC Bioinformatics, machine learning

The scientific literature documenting this field has grown explosively. Over the past two decades, publications on epigenetic epidemiology have multiplied in both number and variety, and the scope of the research now extends well beyond the DNA methylation markers that once dominated the field. Histone modifications and non-coding RNAs have joined the toolbox, and the study designs on display range from epigenome-wide association studies, commonly known as EWAS, to candidate gene studies and clinical trials. Epigenetic markers appear in the literature in two distinct roles. Sometimes they are investigated as risk factors, as in studies of DNA methylation patterns associated with the incidence of type 2 diabetes. Sometimes they are investigated as outcomes, as in research documenting methylation changes in response to air pollution. Keeping track of this expanding and heterogeneous body of work has become a genuine challenge, and that challenge motivated a team of researchers affiliated with the Centers for Disease Control and Prevention and Emory University to build a purpose-made solution.

The result is the Epigenetic Epidemiology Publications Database, or EEPD, a publicly available, web-based application described in a recent correspondence published in Epigenetics Communications. The database is designed to offer a user-friendly way to explore the literature at the intersection of epigenetics, epidemiology, and public health. The scope of the collection is carefully defined. The developers aimed to include population-based studies of epigenetics in association with an exposure or outcome of interest, systematic reviews related to epigenetic associations, and published descriptions of epigenetic resources such as cohorts, protocols, and methods. Just as important is what the database excludes: articles focused on gene expression, including transcriptomics, non-population-based laboratory studies, non-human studies, and non-systematic reviews are all filtered out. That boundary keeps the collection focused on the population perspective that defines the field.

The technical machinery behind the database is where the project becomes genuinely interesting for anyone following the application of machine learning to scientific curation. Manually screening the biomedical literature is notoriously labor-intensive, and the volume of relevant publications makes hand-curation impractical at scale. The team therefore developed an automatic screening process that begins with a PubMed query and then applies a machine learning method, a support vector machine, combined with text mining techniques. Support vector machines are supervised learning algorithms that classify items into categories after being trained on labeled examples, and they have a long track record in text classification tasks. To evaluate how well their pipeline performed, the researchers assessed it against a random sample of 1,999 manually annotated abstracts. Of these, 285 positive records and 114 negative records were reserved for testing. The results were striking: the screening process achieved an estimated area under the curve of 96.4 percent, with 90 percent sensitivity and 90 percent specificity. In practical terms, the automated system caught the overwhelming majority of relevant articles while correctly discarding most irrelevant ones, a level of performance that rivals careful human screening at a fraction of the effort.

Once the screening pipeline is in place, the database essentially runs itself. Records are automatically selected and uploaded on a daily basis, which means the collection stays current without a team of curators reading every new abstract. Each record is indexed with genes, diseases, and other factors, creating a structured layer of metadata on top of the raw publication records. The system also automatically subsets the data according to 14 special topics, ranging from cancer and diabetes to environmental health, health equity, infectious diseases, neurological disorders, pharmacogenomics, rare diseases, and reproductive and child health. These subsets are generated by searching the database with topic-relevant terms, so a researcher interested specifically in, say, heart, lung, blood and sleep disorders can work within a curated slice of the literature rather than the full collection.

The payoff from all this automation is best illustrated by a direct comparison the authors conducted. On September 28, 2023, a search for cancer-related epigenetic epidemiology on EEPD returned 8,942 records. A search on PubMed using the terms cancer, epigenetics, and epidemiology returned only 1,198 records, a dramatic undercount that reflects how often relevant studies fail to use all three terms in their indexing. Removing the epidemiology term from the PubMed search pushed the result to 17,927 records, but at the cost of flooding the searcher with irrelevant material. The EEPD sits in the sweet spot between those two failures, capturing relevant work that conventional keyword searches miss while excluding the noise that broader searches admit. For researchers conducting literature reviews, that difference is not a convenience; it can determine whether a review is comprehensive or fundamentally incomplete.

Using the database is deliberately simple. Users type a query of interest into a search box at the top of the page, and results are returned as a list of related publications. From there, filtering functions allow progressive refinement using indexed factors including gene, disease, publication year, publication journal, and study design. Filters can be applied continuously until the desired result set is achieved, and the final results can be downloaded as an Excel spreadsheet with a single click on the download button. Alternatively, users can subset the entire database to one of the 14 special topics through a dropdown menu in the search bar, and all of the navigation functions remain available within that subset. The design philosophy is clear: the database should spare investigators from having to construct complicated PubMed queries while still offering the precision that expert searchers demand.

The scale of the collection as of August 18, 2023, underscores how much material the automated pipeline has already accumulated. The database contained 21,699 PubMed records, indexed against 9,378 genes and 1,019 disease terms. The annual number of publications has increased markedly since 2000, reflecting the field’s rapid maturation. Cancer dominates the collection as the most studied topic, followed by rare diseases. The five most frequently indexed disease terms are breast neoplasm, colorectal neoplasms, squamous cell carcinoma, lung neoplasm, and stomach neoplasms, a roster that mirrors the prominence of oncology in epigenetic research more broadly. On the gene side, the five most frequently indexed entries are CDKN2A, RASSF1, DNMT1, MGMT, and CDH1, names that will be immediately familiar to anyone who has followed methylation research in tumor biology, since several of these genes are classic targets of epigenetic silencing in cancer.

The authors are candid about the limitations of their tool. The sensitivity of EEPD is not perfect, and the search algorithms and indexing processes of both PubMed and the database have inherent constraints in a field that is rapidly evolving and not fully defined. Because EEPD relies exclusively on PubMed as its data source, potentially relevant articles not indexed there are simply not included, which means the database cannot claim exhaustive coverage of the global literature. These caveats matter, and the authors do not shy away from them. Even so, they argue that EEPD can serve as a valuable complement to traditional search methods for literature review, offering investigators an efficient way to gain an overview of available research on a particular topic as well as to identify articles relevant to their own projects without labor-intensive screening.

The roadmap for the future is equally pragmatic. The authors hope to expand the data sources feeding the database, drawing on resources such as Scopus and Embase to capture material that PubMed misses. Further tuning of the PubMed search query and of the database’s own algorithms could enhance both the sensitivity and specificity of data collection and retrieval, pushing the already strong performance metrics even higher. For a field that sits at the crossroads of epigenetics, epidemiology, and public health, and that produces new publications at an accelerating pace, tools like EEPD may prove essential infrastructure. The promise of epigenetic epidemiology, linking the environments and experiences of populations to the molecular marks that shape disease risk, depends on researchers being able to find, synthesize, and build upon the work of their predecessors. By automating the discovery of that work, the Epigenetic Epidemiology Publications Database aims to make sure that no important study is lost in the sheer volume of an exploding literature.

Subject of Research: A machine learning-curated public database for navigating epigenetic epidemiology literature

Article Title: Navigating epigenetic epidemiology publications

Article References: Yu, W., Drzymalla, E., Gyorfy, M. F., Khoury, M. J., Sun, Y. V., & Gwinn, M. (2023). Navigating epigenetic epidemiology publications. Epigenetics Communications, 3(1), Article 8. https://doi.org/10.1186/s43682-023-00023-3

Image Credits: AI Generated

DOI: 10.1186/s43682-023-00023-3

Keywords: epigenetics, epidemiology, DNA methylation, machine learning, support vector machine, PubMed, database, EWAS, cancer, public health, text mining, literature curation

The motivation behind Polaris reflects a well-documented problem in evidence synthesis. Literature reviews are essential across disciplines: in the health sciences they track rapidly evolving methods of human care, in geography they have shaped frameworks from economic geography to the geography of poverty, and in interdisciplinary fields such as climate science they assess impacts on ecosystems and social inequalities. There are at least fourteen recognized review typologies, ranging from rapid and scoping reviews to full systematic reviews with meta-analysis. Yet conducting any of them well is time-consuming, particularly during bibliographic database searches, supplementary searches, and the review of each retrieved manuscript for inclusion or exclusion. Existing software such as Covidence and Rayyan helps with screening and selection, while tools like ASySD, Deduklick, BibexPy, and the Systematic Review Accelerator handle deduplication and bibliographic processing. Polaris deliberately targets a different stage: retrieval itself, the point where bias and errors most easily creep in.

Bias in literature searching can arise from the researcher’s own decisions, including selective choices of databases, filters, and search terms. When the systematic process behind a review is not fully disclosed, reproducibility suffers. Errors, meanwhile, can stem from technical and procedural limitations during data retrieval: incomplete metadata, missing author information, export restrictions, or, in the case of Google Scholar, the requirement to visit each paper’s website individually to download metadata. To combat these problems, the developers grounded Polaris in established methodological guidance. The tool follows the eight-stage model of literature searching described by Cooper and colleagues, and it aligns with the PRISMA framework, the widely adopted set of twenty-seven recommendations for reporting systematic reviews and meta-analyses. By standardizing retrieval, automating exports, preserving query logs, and improving the auditability of searches, Polaris aims to reduce potential bias and errors before screening even begins.

Technically, Polaris 1.0 is implemented in R, requiring version 4.5.1 or higher, and built on packages including httr, lite, dplyr, stringr, purrr, xml2, zip, and httr2. The architecture has two layers. The front end is a graphical user interface built with the R Shiny package, where users configure search parameters and monitor progress in real time. The back end is a processing engine with an additional asynchronous execution layer to support long-running searches, organized into modular components for software environment configuration, directory and file handling, database-specific retrieval functions, and the core engine. Users supply their queries in a simple TXT file, select the desired databases, and the software accesses each provider through its official API, retrieves the results, generates harmonized metadata, and saves each query’s output as a Research Information System (RIS) file compatible with Mendeley, Zotero, and EndNote.

Each database demands its own handling, and Polaris implements a dedicated retrieval workflow for every supported provider. PubMed is accessed through the NCBI E-utilities API in three steps: the esearch endpoint counts matching records and retrieves PubMed identifiers in batches of up to 300, the efetch endpoint collects abstracts in XML format parsed with the xml2 package, and the summary endpoint returns structured metadata including title, authors, journal, year, abstract, and DOI in JSON. No personal API key is needed, and a 0.4-second delay between requests keeps the tool compliant with PubMed policies. Scopus and ScienceDirect both rely on the Elsevier API, which requires an API key and an institutional token. Scopus queries are automatically wrapped in the TITLE-ABS-KEY field while preserving the user’s Boolean logic, and ScienceDirect searches title, abstract, keywords, and full text, with abstracts conveniently stored in the description field of the response. Semantic Scholar, which needs no key, uses a bulk search endpoint that supports Boolean expressions, with Polaris translating operators such as AND, OR, and NOT into the provider’s required syntax while preserving the logical structure of the original strategy.

A distinctive strength of the system is its three-level logging design. The first level feeds a real-time monitoring dashboard, updating users on execution status until each search completes. The second, a master log, records comprehensive metadata across all databases: the date and time each query ran, the source database, the query structure, the total number of papers retrieved, the exported RIS filename, and the search status. The third level maintains database-specific logs with the same structure. Together these logs document exactly which queries were executed, where, when, and with what results, making the entire retrieval stage auditable and reproducible. Polaris also handles Elsevier’s authentication errors gracefully: HTTP 401 and 403 errors terminate the affected request and prompt users to verify their credentials, while HTTP 429 rate-limiting responses trigger a temporary pause before retry, all displayed on the dashboard.

To demonstrate reliability, the team compared Polaris retrieval counts against the official web interfaces of PubMed, Scopus, and ScienceDirect across 60 queries, 20 per database, using identical search strings and equivalent fields. Agreement was assessed with linear regression, Pearson’s correlation, Bland–Altman analysis, and relative percentage differences. The results were striking: a Pearson correlation coefficient of r = 1.000 and a coefficient of determination R² = 1.000, with points closely following the identity line across searches ranging from a handful of records to several thousand. The Bland–Altman mean difference, or bias, was just −7.92 records, a negligible proportion for searches returning more than 5,000 results. Nearly all observations fell within the 95% limits of agreement. The mean relative difference was −0.15% and the median 0.00%, meaning most searches produced identical counts. PubMed and Scopus showed almost complete agreement, while ScienceDirect displayed a small number of larger but still limited deviations. A log-transformed Bland–Altman analysis estimated a bias of only −0.0007 log units, confirming that discrepancies do not grow with search size. The complete validation dataset and R scripts are publicly available on GitHub and archived on Zenodo.

The software does have limitations tied to each provider’s API. Without a key, PubMed caps results at 10,000 per query; ScienceDirect allows 6,000 under an API and institutional key; Scopus imposes no limit on broad retrievals; and Semantic Scholar is limited to roughly the first 300 results. Validation for Semantic Scholar was not possible because its webpage and API return different results, and for queries hitting a provider’s maximum, Polaris was considered to have correctly handled the constraint rather than achieving perfect agreement. Future versions plan to add front-end filters for year, field, and study design, along with support for the IEEE and SciELO databases to broaden coverage to engineering and Latin American literature.

Early applications suggest Polaris can scale to demanding real-world projects. In a critical review of outdoor workers and heat exposure in the United States, the software handled approximately 100,000 results drawn from multiple databases. In a systematic review of human attitudes and behavior toward snakes, queries using Boolean operators, parentheses, and asterisk truncation retrieved 21,734 records in preliminary results, demonstrating robust handling of complex syntax and special characters. Because repetitive tasks such as copying queries across platforms and manually exporting results are automated, and real-time monitoring catches interruptions during long runs, the developers argue that Polaris shifts literature retrieval from a manual, platform-dependent chore toward a standardized, traceable workflow. Its MIT-licensed R and Shiny code base makes it straightforward to adapt, extend, and reuse, potentially changing how evidence synthesis is conducted day to day in an era of ever-expanding publication volume.

Subject of Research: An automated, open-source software system for multi-database bibliographic literature retrieval supporting reproducible systematic reviews

Article Title: Polaris – an automated literature retrieval system

Article References: Prado, L. B. D., Vanos, J., & Rosales-Chávez, J. B. (2026). Polaris – an automated literature retrieval system. SoftwareX, 36, Article 103024. https://doi.org/10.1016/j.softx.2026.103024

Image Credits: AI Generated

DOI: 10.1016/j.softx.2026.103024

Keywords: Polaris, literature retrieval, systematic reviews, bibliographic databases, PRISMA, open-source software, R Shiny, PubMed, Scopus, ScienceDirect, Semantic Scholar, reproducibility

Dermatology has long been among the most competitive specialties in the National Resident Matching Program. With a limited number of positions, high board scores historically expected, and a lifestyle that attracts large applicant pools, the field has developed one of the most demanding unofficial credential portfolios in graduate medical education. Previous analyses, including work published in JAMA Dermatology, documented a steady rise in the research output of medical students matching into dermatology between 2007 and 2018, a trend some commentators have described as research fever. The new study asks whether that fever intensified once Step 1 scores could no longer differentiate applicants numerically.

The rationale for the investigation rests on a simple structural fact. Before the transition, a high Step 1 score served as a widely used screening filter, allowing program directors to rank candidates quickly and giving applicants a clear, if stressful, way to demonstrate academic strength. When scoring became binary, that signal disappeared. Students who might once have relied on a strong score to compensate for thinner research records suddenly faced a signaling vacuum, and many appear to have responded by accelerating their publication efforts. The SUNY Downstate team set out to quantify whether the applicants entering elite dermatology programs indeed became more research-productive in the immediate aftermath of the change.

Methodologically, the researchers constructed an applicant-level dataset by tracing publication records through PubMed, the publicly accessible bibliographic database maintained by the National Library of Medicine. By linking successful applicants to the top Doximity-ranked dermatology programs with their indexed scholarly records, the team could count manuscripts, characterize authorship positions, and compare productivity across the pre-transition and post-transition eras. The compiled dataset was analyzed to detect shifts in the volume and pattern of research output, with the authors reporting their comparisons in graphical form across two figures in the short report. The use of PubMed as the source of publication records means the analysis captures indexed journal articles, the most verifiable form of student research output.

The study’s central observation is that research productivity among applicants to top-ranked dermatology programs did not decline after Step 1 became pass/fail; rather, the pressure to publish appears to have persisted or grown in the immediate post-transition period. This aligns with what residency directors anecdotally report: when one differentiator is removed from the application, others expand to fill the space. Publications, particularly peer-reviewed manuscripts with meaningful authorship roles, offer a quantifiable, durable signal of initiative, intellectual curiosity, and the capacity to complete a long-term project, qualities that a pass/fail exam can no longer convey with any granularity.

The findings carry particular weight because dermatology sits at the extreme end of the competitiveness spectrum. Prior work by Behbahani and colleagues in the International Journal of Women’s Dermatology analyzed the number of manuscripts in successful dermatology applications and found that publications were a common feature of matched candidates. A related 2025 analysis by Abizadeh and colleagues, which included several of the same SUNY Downstate investigators, documented similar dynamics in ophthalmology, another highly competitive specialty that also experienced the Step 1 transition. Together, these studies suggest a broader pattern across competitive fields: the removal of numerical Step 1 scores has shifted, not lightened, the burden of differentiation onto other parts of the application.

That shift has consequences for equity. Research productivity is not distributed evenly across medical students. Access to mentorship, dedicated research time, institutional funding, and proximity to academic medical centers all shape a student’s ability to publish before applying. Students at resource-rich institutions with established dermatology departments can more easily find projects, co-authors, and submission support, while students at schools without such infrastructure face structural barriers. If publications become the dominant differentiator in the post-pass/fail era, the authors’ findings imply that the transition may have amplified existing inequities rather than reduced them, a concern echoed in a 2023 JAMA Dermatology commentary describing research fever in dermatology as a symptom of a larger problem within the specialty’s selection culture.

The study also speaks to the ongoing debate about holistic review in residency selection. Proponents of the Step 1 pass/fail change argued that it would reduce student stress, discourage rote test preparation, and encourage programs to evaluate candidates on a broader set of attributes, including clinical performance, letters of recommendation, and personal qualities. The SUNY Downstate results suggest that at least one intended consequence, a de-emphasis on credential accumulation, has not materialized in elite dermatology recruitment. Instead, the credential economy appears to have migrated from the exam score to the curriculum vitae, with students responding rationally to the incentives programs continue to reward.

For medical educators and advisors, the practical implications are immediate. Students targeting competitive specialties now need earlier and more deliberate research planning, ideally beginning in the preclinical years, to build a publication record that can withstand comparison in a post-transition applicant pool. Programs, meanwhile, face a choice: continue to reward publication counts, thereby sustaining the arms race, or develop more structured ways to assess the quality and authenticity of research experiences, such as standardized descriptions of the applicant’s actual role and contribution. The authors of the current study, funded by the SUNY Downstate Health Sciences University Dermatology Department, frame their work as a snapshot of a system in transition, and they note that longer-term follow-up across additional match cycles will be needed to determine whether the patterns observed immediately after the change persist, stabilize, or prompt reform in how dermatology programs select the next generation of specialists.

Subject of Research: Research productivity of applicants to top Doximity-ranked dermatology residency programs in the USA before and after the Step 1 pass/fail transition

Article Title: Research productivity among applicants into top Doximity-ranked dermatology programs in the USA before and immediately after step 1 transition to pass/fail scoring

Article References: Shimshon, H. K., Berglas, R., Lavi, A. B., Berglas, E., Adler, R., Pinto, R., Musheyev, D., Shimanov, M. M., Farahmandpour, N., Inoyatov, I., & Glick, S. (2026). Research productivity among applicants into top Doximity-ranked dermatology programs in the USA before and immediately after step 1 transition to pass/fail scoring. Archives of Dermatological Research, 318(1), Article 409. https://doi.org/10.1007/s00403-026-04893-0

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04893-0

Keywords: dermatology, residency match, Step 1 pass/fail, research productivity, medical education, NRMP, publications, Doximity rankings, USMLE, competitive specialties, PubMed, SUNY Downstate